CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-12-18 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +1,200,000 | 1,200,000 | ||
| 2008-12-18 | Clavijo James Controller/Treasurer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2007-09-27 | KUO JAMES S Director | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2007-09-27 | Buhrman Cyrille F Director | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2007-08-29 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Purchase | +70,000 | $0.31 | $22K | 224,780 |
| 2007-08-28 | Clavijo James Controller/Treasurer | Purchase | +35,000 | $0.30 | $10K | 88,191 |
| 2007-08-28 | SCHABER CHRISTOPHER J Chief Executive Officer | Purchase | +100,000 | $0.29 | $29K | 392,766 |
| 2007-08-10 | Brey Robert N Chief Scientific Officer/SrVP | Grant or award · Stock Options (Right to Buy) | +200,000 | 200,000 | ||
| 2007-08-10 | KUO JAMES S Director | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2007-08-10 | Clavijo James Controller/Treasurer | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2007-08-10 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +550,000 | 550,000 | ||
| 2007-08-10 | SCHABER CHRISTOPHER J Chief Executive Officer | Grant or award · Stock Options (right ot buy) | +500,000 | 500,000 | ||
| 2007-08-10 | SCHABER CHRISTOPHER J Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +900,000 | 900,000 | ||
| 2007-08-10 | KUO JAMES S Director | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2007-06-28 | Buhrman Cyrille F Director | Grant or award · Stock Options (right to buy) | +150,000 | 150,000 | ||
| 2007-02-09 | Clavijo James Controller/Treasurer | Purchase | +53,191 | $0.47 | $25K | 53,191 |
| 2007-02-09 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Purchase | +53,191 | $0.47 | $25K | 154,817 |
| 2007-02-09 | SCHABER CHRISTOPHER J Chief Executive Officer | Purchase | +212,766 | $0.47 | $100K | 292,766 |
| 2007-02-09 | KANZER STEVE H Director | Purchase | +212,766 | $0.47 | $100K | 1,282,203 |
| 2007-01-24 | KUO JAMES S Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 17 of 22 · 422 trades